rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Vijay Chandru

Director

Company insider

Files Form 4 as: Director, Lantern Pharma.

In numbers

Trades disclosed
12
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
1
Companies where not an officer
1
First trade
15 Jun 2020
Last trade
9 Jan 2026
Last filed
13 Jan 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
LTRN Lantern PharmaDirector · Biotechnology · last 9 Jan 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
9 Jan 2026filed 13 Jan 2026LTRN Lantern Pharmaoption or derivative · BiotechnologySEC FORM 4 Code A—25,000 at $0.00filing
9 Jan 2026filed 13 Jan 2026LTRN Lantern Pharmaoption or derivative · BiotechnologySEC FORM 4 Code A—17,307 at $0.00filing
9 Jan 2026filed 13 Jan 2026LTRN Lantern Pharmaoption or derivative · BiotechnologySEC FORM 4 Code A—25,000 at $0.00filing
9 Jan 2026filed 13 Jan 2026LTRN Lantern Pharmaoption or derivative · BiotechnologySEC FORM 4 Code A—17,307 at $0.00filing
15 Jul 2024filed 17 Jul 2024LTRN Lantern Pharmaoption or derivative · BiotechnologySEC FORM 4 Code A—5,000 at $0.00filing
15 Jul 2024filed 17 Jul 2024LTRN Lantern Pharmaoption or derivative · BiotechnologySEC FORM 4 Code A—5,000 at $0.00filing
4 Nov 2021filed 23 Sep 2025LTRN Lantern Pharmaoption or derivative · BiotechnologySEC FORM 4 Code D—3,200 at $0.00filing
4 Nov 2021filed 23 Sep 2025LTRN Lantern Pharmaoption or derivative · BiotechnologySEC FORM 4 Code A—3,200 at $0.00filing
4 Nov 2021filed 8 Nov 2021LTRN Lantern Pharmaoption or derivative · BiotechnologySEC FORM 4 Code A—3,200 at $0.00filing
15 Jun 2020filed 23 Sep 2025LTRN Lantern Pharmaoption or derivative · BiotechnologySEC FORM 4 Code D—9,135 at $0.00filing
15 Jun 2020filed 23 Sep 2025LTRN Lantern Pharmaoption or derivative · BiotechnologySEC FORM 4 Code A—9,135 at $0.00filing
15 Jun 2020filed 15 Jun 2020LTRN Lantern Pharmaoption or derivative · BiotechnologySEC FORM 4 Code A—9,135filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

D. Jeffrey KeyserDirector · Director at Lantern Pharma, filing Form 4 there in the last year
Lee Troy SchalopDirector · Director at Lantern Pharma, filing Form 4 there in the last year
Maria-Luisa MaccecchiniDirector · Director at Lantern Pharma, filing Form 4 there in the last year
David S. SilbersteinDirector · Director at Lantern Pharma, filing Form 4 there in the last year